Global SGLT2 Inhibitors Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global SGLT2 Inhibitors Consumption Value by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Canagliflozin
  • 1.3.3 Dapagliflozin
  • 1.3.4 Canagliflozin
  • 1.3.5 Other
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global SGLT2 Inhibitors Consumption Value by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Single Drug
  • 1.4.3 Combination Medication
• 1.5 Global SGLT2 Inhibitors Market Size & Forecast
  • 1.5.1 Global SGLT2 Inhibitors Consumption Value (2020 & 2024 & 2031)
  • 1.5.2 Global SGLT2 Inhibitors Sales Quantity (2020-2031)
  • 1.5.3 Global SGLT2 Inhibitors Average Price (2020-2031)

2 Manufacturers Profiles

• 2.1 AstraZeneca
  • 2.1.1 AstraZeneca Details
  • 2.1.2 AstraZeneca Major Business
  • 2.1.3 AstraZeneca SGLT2 Inhibitors Product and Services
  • 2.1.4 AstraZeneca SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 AstraZeneca Recent Developments/Updates
• 2.2 Hengrui Medicine
  • 2.2.1 Hengrui Medicine Details
  • 2.2.2 Hengrui Medicine Major Business
  • 2.2.3 Hengrui Medicine SGLT2 Inhibitors Product and Services
  • 2.2.4 Hengrui Medicine SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Hengrui Medicine Recent Developments/Updates
• 2.3 Johnson and Johnson
  • 2.3.1 Johnson and Johnson Details
  • 2.3.2 Johnson and Johnson Major Business
  • 2.3.3 Johnson and Johnson SGLT2 Inhibitors Product and Services
  • 2.3.4 Johnson and Johnson SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Johnson and Johnson Recent Developments/Updates
• 2.4 Kelun Pharmaceutical
  • 2.4.1 Kelun Pharmaceutical Details
  • 2.4.2 Kelun Pharmaceutical Major Business
  • 2.4.3 Kelun Pharmaceutical SGLT2 Inhibitors Product and Services
  • 2.4.4 Kelun Pharmaceutical SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Kelun Pharmaceutical Recent Developments/Updates
• 2.5 Chia Tai-Tianqing Pharmaceutical
  • 2.5.1 Chia Tai-Tianqing Pharmaceutical Details
  • 2.5.2 Chia Tai-Tianqing Pharmaceutical Major Business
  • 2.5.3 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product and Services
  • 2.5.4 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
• 2.6 Hansoh Pharmaceutical Group
  • 2.6.1 Hansoh Pharmaceutical Group Details
  • 2.6.2 Hansoh Pharmaceutical Group Major Business
  • 2.6.3 Hansoh Pharmaceutical Group SGLT2 Inhibitors Product and Services
  • 2.6.4 Hansoh Pharmaceutical Group SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Hansoh Pharmaceutical Group Recent Developments/Updates
• 2.7 Orifarm
  • 2.7.1 Orifarm Details
  • 2.7.2 Orifarm Major Business
  • 2.7.3 Orifarm SGLT2 Inhibitors Product and Services
  • 2.7.4 Orifarm SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Orifarm Recent Developments/Updates
• 2.8 Starpharma
  • 2.8.1 Starpharma Details
  • 2.8.2 Starpharma Major Business
  • 2.8.3 Starpharma SGLT2 Inhibitors Product and Services
  • 2.8.4 Starpharma SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 Starpharma Recent Developments/Updates
• 2.9 Sandoz
  • 2.9.1 Sandoz Details
  • 2.9.2 Sandoz Major Business
  • 2.9.3 Sandoz SGLT2 Inhibitors Product and Services
  • 2.9.4 Sandoz SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 Sandoz Recent Developments/Updates
• 2.10 Bristol-Myers Squibb
  • 2.10.1 Bristol-Myers Squibb Details
  • 2.10.2 Bristol-Myers Squibb Major Business
  • 2.10.3 Bristol-Myers Squibb SGLT2 Inhibitors Product and Services
  • 2.10.4 Bristol-Myers Squibb SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 Bristol-Myers Squibb Recent Developments/Updates
• 2.11 Boehringer Ingelheim
  • 2.11.1 Boehringer Ingelheim Details
  • 2.11.2 Boehringer Ingelheim Major Business
  • 2.11.3 Boehringer Ingelheim SGLT2 Inhibitors Product and Services
  • 2.11.4 Boehringer Ingelheim SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.11.5 Boehringer Ingelheim Recent Developments/Updates
• 2.12 Merck
  • 2.12.1 Merck Details
  • 2.12.2 Merck Major Business
  • 2.12.3 Merck SGLT2 Inhibitors Product and Services
  • 2.12.4 Merck SGLT2 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.12.5 Merck Recent Developments/Updates

3 Competitive Environment: SGLT2 Inhibitors by Manufacturer

• 3.1 Global SGLT2 Inhibitors Sales Quantity by Manufacturer (2020-2025)
• 3.2 Global SGLT2 Inhibitors Revenue by Manufacturer (2020-2025)
• 3.3 Global SGLT2 Inhibitors Average Price by Manufacturer (2020-2025)
• 3.4 Market Share Analysis (2024)
  • 3.4.1 Producer Shipments of SGLT2 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2024
  • 3.4.2 Top 3 SGLT2 Inhibitors Manufacturer Market Share in 2024
  • 3.4.3 Top 6 SGLT2 Inhibitors Manufacturer Market Share in 2024
• 3.5 SGLT2 Inhibitors Market: Overall Company Footprint Analysis
  • 3.5.1 SGLT2 Inhibitors Market: Region Footprint
  • 3.5.2 SGLT2 Inhibitors Market: Company Product Type Footprint
  • 3.5.3 SGLT2 Inhibitors Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global SGLT2 Inhibitors Market Size by Region
  • 4.1.1 Global SGLT2 Inhibitors Sales Quantity by Region (2020-2031)
  • 4.1.2 Global SGLT2 Inhibitors Consumption Value by Region (2020-2031)
  • 4.1.3 Global SGLT2 Inhibitors Average Price by Region (2020-2031)
• 4.2 North America SGLT2 Inhibitors Consumption Value (2020-2031)
• 4.3 Europe SGLT2 Inhibitors Consumption Value (2020-2031)
• 4.4 Asia-Pacific SGLT2 Inhibitors Consumption Value (2020-2031)
• 4.5 South America SGLT2 Inhibitors Consumption Value (2020-2031)
• 4.6 Middle East & Africa SGLT2 Inhibitors Consumption Value (2020-2031)

5 Market Segment by Type

• 5.1 Global SGLT2 Inhibitors Sales Quantity by Type (2020-2031)
• 5.2 Global SGLT2 Inhibitors Consumption Value by Type (2020-2031)
• 5.3 Global SGLT2 Inhibitors Average Price by Type (2020-2031)

6 Market Segment by Application

• 6.1 Global SGLT2 Inhibitors Sales Quantity by Application (2020-2031)
• 6.2 Global SGLT2 Inhibitors Consumption Value by Application (2020-2031)
• 6.3 Global SGLT2 Inhibitors Average Price by Application (2020-2031)

7 North America

• 7.1 North America SGLT2 Inhibitors Sales Quantity by Type (2020-2031)
• 7.2 North America SGLT2 Inhibitors Sales Quantity by Application (2020-2031)
• 7.3 North America SGLT2 Inhibitors Market Size by Country
  • 7.3.1 North America SGLT2 Inhibitors Sales Quantity by Country (2020-2031)
  • 7.3.2 North America SGLT2 Inhibitors Consumption Value by Country (2020-2031)
  • 7.3.3 United States Market Size and Forecast (2020-2031)
  • 7.3.4 Canada Market Size and Forecast (2020-2031)
  • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

• 8.1 Europe SGLT2 Inhibitors Sales Quantity by Type (2020-2031)
• 8.2 Europe SGLT2 Inhibitors Sales Quantity by Application (2020-2031)
• 8.3 Europe SGLT2 Inhibitors Market Size by Country
  • 8.3.1 Europe SGLT2 Inhibitors Sales Quantity by Country (2020-2031)
  • 8.3.2 Europe SGLT2 Inhibitors Consumption Value by Country (2020-2031)
  • 8.3.3 Germany Market Size and Forecast (2020-2031)
  • 8.3.4 France Market Size and Forecast (2020-2031)
  • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
  • 8.3.6 Russia Market Size and Forecast (2020-2031)
  • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

• 9.1 Asia-Pacific SGLT2 Inhibitors Sales Quantity by Type (2020-2031)
• 9.2 Asia-Pacific SGLT2 Inhibitors Sales Quantity by Application (2020-2031)
• 9.3 Asia-Pacific SGLT2 Inhibitors Market Size by Region
  • 9.3.1 Asia-Pacific SGLT2 Inhibitors Sales Quantity by Region (2020-2031)
  • 9.3.2 Asia-Pacific SGLT2 Inhibitors Consumption Value by Region (2020-2031)
  • 9.3.3 China Market Size and Forecast (2020-2031)
  • 9.3.4 Japan Market Size and Forecast (2020-2031)
  • 9.3.5 South Korea Market Size and Forecast (2020-2031)
  • 9.3.6 India Market Size and Forecast (2020-2031)
  • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
  • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

• 10.1 South America SGLT2 Inhibitors Sales Quantity by Type (2020-2031)
• 10.2 South America SGLT2 Inhibitors Sales Quantity by Application (2020-2031)
• 10.3 South America SGLT2 Inhibitors Market Size by Country
  • 10.3.1 South America SGLT2 Inhibitors Sales Quantity by Country (2020-2031)
  • 10.3.2 South America SGLT2 Inhibitors Consumption Value by Country (2020-2031)
  • 10.3.3 Brazil Market Size and Forecast (2020-2031)
  • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

• 11.1 Middle East & Africa SGLT2 Inhibitors Sales Quantity by Type (2020-2031)
• 11.2 Middle East & Africa SGLT2 Inhibitors Sales Quantity by Application (2020-2031)
• 11.3 Middle East & Africa SGLT2 Inhibitors Market Size by Country
  • 11.3.1 Middle East & Africa SGLT2 Inhibitors Sales Quantity by Country (2020-2031)
  • 11.3.2 Middle East & Africa SGLT2 Inhibitors Consumption Value by Country (2020-2031)
  • 11.3.3 Turkey Market Size and Forecast (2020-2031)
  • 11.3.4 Egypt Market Size and Forecast (2020-2031)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
  • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

• 12.1 SGLT2 Inhibitors Market Drivers
• 12.2 SGLT2 Inhibitors Market Restraints
• 12.3 SGLT2 Inhibitors Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of SGLT2 Inhibitors and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of SGLT2 Inhibitors
• 13.3 SGLT2 Inhibitors Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 SGLT2 Inhibitors Typical Distributors
• 14.3 SGLT2 Inhibitors Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source